DNA X, Inc. (SONM) investor Lytton discloses 6.8% stake in latest 13G/A
Rhea-AI Filing Summary
DNA X, Inc. reports that investor Laurence W. Lytton beneficially owns 100,521 shares of its common stock, representing 6.8% of the class. This ownership consists of 61,633 shares with sole voting and dispositive power and 38,888 shares with shared voting and dispositive power.
The ownership percentage is based on 1,488,268 shares of common stock outstanding as of May 14, 2026. Lytton also holds warrants to purchase 22,222 additional shares that are excluded from the reported beneficial ownership due to a 4.99% beneficial ownership limitation on those warrants.
Positive
- None.
Negative
- None.
Key Figures
Beneficially owned shares: 100,521 shares
Ownership percentage: 6.8%
Shares outstanding: 1,488,268 shares
+4 more
7 metrics
Beneficially owned shares
100,521 shares
Common stock beneficially owned by Laurence W. Lytton
Ownership percentage
6.8%
Percent of DNA X, Inc. common stock class owned by Lytton
Shares outstanding
1,488,268 shares
Common stock outstanding on May 14, 2026
Sole voting/dispositive power
61,633 shares
Shares over which Lytton has sole voting and dispositive power
Shared voting/dispositive power
38,888 shares
Shares over which Lytton has shared voting and dispositive power
Warrants excluded
22,222 shares
Shares underlying warrants excluded due to 4.99% beneficial ownership limitation
Beneficial ownership cap
4.99%
Limitation applied to warrant exercises for beneficial ownership
Key Terms
beneficially owned, sole voting power, shared voting power, beneficial ownership limitation, +1 more
5 terms
beneficially owned financial
"The shares of Common Stock beneficially owned by the reporting person excludes warrants"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole voting power financial
"Sole Voting Power 61,633.00 6 | Shared Voting Power 38,888.00"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
beneficial ownership limitation regulatory
"warrants to purchase 22,222 shares of Common Stock, which are subject to a 4.99% beneficial ownership limitation"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.
dispositive power financial
"Sole Dispositive Power 61,633.00 8 | Shared Dispositive Power 38,888.00"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
FAQ
How much of DNA X, Inc. does investor Laurence W. Lytton own according to the SONM Schedule 13G/A?
Laurence W. Lytton beneficially owns 100,521 shares of DNA X, Inc. common stock, representing 6.8% of the outstanding class, based on 1,488,268 shares outstanding as of May 14, 2026.
How was Laurence W. Lytton’s 6.8% ownership in DNA X, Inc. calculated in the SONM Schedule 13G/A?
The 6.8% ownership is calculated using 1,488,268 shares of DNA X, Inc. common stock outstanding on May 14, 2026, as referenced from the issuer’s Form 10-Q for the quarter ended March 31, 2026.
What class of securities in DNA X, Inc. does the SONM Schedule 13G/A cover for Laurence W. Lytton?
The filing covers common stock of DNA X, Inc., identified by CUSIP 83548F309, with Lytton reporting beneficial ownership and detailing his sole and shared voting and dispositive powers over the shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.